Bioinspired polydopamine as a versatile platform for pharmaceutical and biomedical applications
Future advancement should pivot from function-driven material development towards the design of application-specific and quality-controlled PDAs, and a shift of this nature is required for the transformation of PDA from a solution material to a predictable, reproducible, and clinically translatable material.